BNP Paribas Financial Markets’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.92M | Buy |
|
|||||
|
2025
Q2 | $1.65M | Buy |
|
|||||
|
2025
Q1 | $230K | Sell |
|
|||||
|
2024
Q4 | $1.37M | Sell |
|
|||||
|
2024
Q3 | $4.58M | Buy |
|
|||||
|
2024
Q2 | $2.37M | Sell |
|
|||||
|
2024
Q1 | $2.69M | Sell |
|
|||||
|
2023
Q4 | $6.05M | Sell |
|
|||||
|
2023
Q3 | $5.63M | Buy |
|
|||||
|
2023
Q2 | $3.87M | Buy |
|
|||||
|
2023
Q1 | $1.19M | Buy |
|
|||||
|
2022
Q4 | $237K | Sell |
|
|||||
|
2022
Q3 | $464K | Sell |
|
|||||
|
2022
Q2 | $1.77M | Sell |
|
|||||
|
2022
Q1 | $4.99M | Sell |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $910K | Buy |
|
|||||
|
2021
Q2 | $457K | Buy |
|
|||||
|
2021
Q1 | $275K | Buy |
|
|||||
|
2020
Q4 | $300K | Sell |
|
|||||
|
2020
Q3 | $298K | Buy |
|
|||||
|
2020
Q2 | $47.7K | Sell |
|
|||||
|
2020
Q1 | $211K | Sell |
|
|||||
|
2019
Q4 | $279K | Buy |
|
|||||
|
2019
Q3 | $251K | Buy |
|
|||||
|
2019
Q2 | $83.7K | Sell |
|
|||||
|
2019
Q1 | $150K | Buy |
|
|||||
|
2018
Q4 | $279 | Sell |
|
|||||
|
2018
Q3 | $23.2K | Hold |
|
|||||
|
2018
Q2 | $18.4K | Sell |
|
|||||
|
2018
Q1 | $221K | Sell |
|
|||||
|
2017
Q4 | $283K | Sell |
|
|||||
|
2017
Q3 | $321K | Buy |
|
|||||
|
2017
Q2 | $188K | Buy |
|
|||||
|
2017
Q1 | $96.6K | Sell |
|
|||||
|
2016
Q4 | $137K | Buy |
|
|||||
|
2016
Q3 | $94K | Buy |
|
|||||
|
2016
Q2 | $22.2K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $86.8K | Sell |
|
|||||
|
2015
Q3 | $79.2K | Buy |
|
|||||
|
2015
Q2 | $46.5K | Buy |
|
|||||
|
2015
Q1 | $3.35K | Buy |
|